Home
Scientific News
Structural Heart Disease
Coronary Disease
Peripheral Vascular Disease
Pharmacology
Educational Newsletters for Fellows
Educational Webinars
Other Content
Congresses
SOLACI-SOCIME 2025 Congress
International Congresses
SOLACI Congresses
Upcoming Events
SOLACI Areas
Sessions
Venezuela Sessions 2025
Costa Rica Sessions 2025
Previous Sessions
About SOLACI Sessions
Authorities
SOLACI Sessions News
ProEducar
Educational Newsletters
Courses for Fellows
The Fellow’s Corner
ProEducar Videos and Webinars
ProEducar News
SOLACI Research
2025 SOLACI Research Grant
LATAM-SOLACI Peripheral Registry
LATAM-BIF SOLACI Registry
Participate in our LATAM-SOLACI Peripheral Registries
SOLACI/SIAC Clinical Guidelines TAVR vs SAVR
SOLACI-SIAC LM Revascularization Guidelines
Authorities
Videos and Webinars
Research News
SOLACI Peripheral
LATAM-SOLACI Peripheral Registry
Videos and Webinars
Authorities
SOLACI Peripheral News
MIL Group
Activities and Initiatives
Videos and Webinars
History, Mission, and Vision
Authorities
Mil Group News
CHIP LATAM SOLACI
Authorities
CHIP LATAM SOLACI News
SOL SOLACI
Authorities
SOL SOLACI News
Congenital Heart Disease
Authorities
Congenital Heart Disease News
SOLACI Technologists and Nurses
Board of Directors
Videos and Webinars
SOLACI Technologists and Nurses News
About SOLACI
About us
Board of Directors
List of members
Become A SOLACI Member
Update your Info (members)
Related Organizations
Institutional News
Contact
Search
Buscar
Buscar
Congreso SOLACI
SOLACI & SBHCI 2026
Bienvenidos al SOLACI & SBHCI 2026
Highlights
Información General
Autoridades
Certificados SOLACI-SOCIME 2025
Facebook
Instagram
Linkedin
X
Youtube
Home
Scientific News
Structural Heart Disease
Coronary Disease
Peripheral Vascular Disease
Pharmacology
Educational Newsletters for Fellows
Educational Webinars
Other Content
Congresses
SOLACI-SOCIME 2025 Congress
International Congresses
SOLACI Congresses
Upcoming Events
SOLACI Areas
Sessions
Venezuela Sessions 2025
Costa Rica Sessions 2025
Previous Sessions
About SOLACI Sessions
Authorities
SOLACI Sessions News
ProEducar
Educational Newsletters
Courses for Fellows
The Fellow’s Corner
ProEducar Videos and Webinars
ProEducar News
SOLACI Research
2025 SOLACI Research Grant
LATAM-SOLACI Peripheral Registry
LATAM-BIF SOLACI Registry
Participate in our LATAM-SOLACI Peripheral Registries
SOLACI/SIAC Clinical Guidelines TAVR vs SAVR
SOLACI-SIAC LM Revascularization Guidelines
Authorities
Videos and Webinars
Research News
SOLACI Peripheral
LATAM-SOLACI Peripheral Registry
Videos and Webinars
Authorities
SOLACI Peripheral News
MIL Group
Activities and Initiatives
Videos and Webinars
History, Mission, and Vision
Authorities
Mil Group News
CHIP LATAM SOLACI
Authorities
CHIP LATAM SOLACI News
SOL SOLACI
Authorities
SOL SOLACI News
Congenital Heart Disease
Authorities
Congenital Heart Disease News
SOLACI Technologists and Nurses
Board of Directors
Videos and Webinars
SOLACI Technologists and Nurses News
About SOLACI
About us
Board of Directors
List of members
Become A SOLACI Member
Update your Info (members)
Related Organizations
Institutional News
Contact
Home
Scientific News
Structural Heart Disease
Coronary Disease
Peripheral Vascular Disease
Pharmacology
Educational Newsletters for Fellows
Educational Webinars
Other Content
Congresses
SOLACI-SOCIME 2025 Congress
International Congresses
SOLACI Congresses
Upcoming Events
SOLACI Areas
Sessions
Venezuela Sessions 2025
Costa Rica Sessions 2025
Previous Sessions
About SOLACI Sessions
Authorities
SOLACI Sessions News
ProEducar
Educational Newsletters
Courses for Fellows
The Fellow’s Corner
ProEducar Videos and Webinars
ProEducar News
SOLACI Research
2025 SOLACI Research Grant
LATAM-SOLACI Peripheral Registry
LATAM-BIF SOLACI Registry
Participate in our LATAM-SOLACI Peripheral Registries
SOLACI/SIAC Clinical Guidelines TAVR vs SAVR
SOLACI-SIAC LM Revascularization Guidelines
Authorities
Videos and Webinars
Research News
SOLACI Peripheral
LATAM-SOLACI Peripheral Registry
Videos and Webinars
Authorities
SOLACI Peripheral News
MIL Group
Activities and Initiatives
Videos and Webinars
History, Mission, and Vision
Authorities
Mil Group News
CHIP LATAM SOLACI
Authorities
CHIP LATAM SOLACI News
SOL SOLACI
Authorities
SOL SOLACI News
Congenital Heart Disease
Authorities
Congenital Heart Disease News
SOLACI Technologists and Nurses
Board of Directors
Videos and Webinars
SOLACI Technologists and Nurses News
About SOLACI
About us
Board of Directors
List of members
Become A SOLACI Member
Update your Info (members)
Related Organizations
Institutional News
Contact
Búsqueda de:
TAVI
Buscar
Si no está conforme con los resultados, inténtelo de nuevamente.
Structural heart disease
Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?
Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment...
Dr. Juan Manuel Pérez
-
26 February, 2026
Ir
Structural heart disease
Can TAVI Be Safely Performed in Patients With Bicuspid Aortic Valve?
Bicuspid aortic valve (BAV) represents an anatomical challenge for transcatheter aortic valve replacement (TAVR) due to the...
Dr. Juan Manuel Pérez
-
19 February, 2026
Ir
Structural heart disease
TAVI in small aortic annulus: self-expanding or balloon-expandable valve in the long term?
Patients with a small aortic annulus (a predominantly female population with a higher risk of prosthesis–patient mismatch)...
Dr. Juan Manuel Pérez
-
5 February, 2026
Ir
Structural heart disease
Long-Term Predictors of Valve Deterioration After TAVI
Transcatheter aortic valve implantation (TAVI) has become an innovative technology for the treatment of patients with severe...
Dr. Andrés Rodríguez
-
30 January, 2026
Ir
Structural heart disease
Coronary access after TAVI with fourth- and fifth-generation Evolut valves: the EPROMPT-CA study
The expansion of transcatheter aortic valve implantation (TAVI) toward younger and lower-risk patients has increased the relevance...
Dr. Juan Manuel Pérez
-
29 January, 2026
Ir
Pharmacology
Is it safe to use negative chronotropic drugs early after TAVI?
TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block...
Dr. Juan Manuel Pérez
-
15 January, 2026
Ir
Structural heart disease
Impact of Amyloidosis on Outcomes After TAVI
Cardiac amyloidosis (CA) is a systemic and progressive disease characterized by the accumulation of misfolded proteins in...
Dr. Juan Manuel Pérez
-
22 October, 2025
Ir
Structural heart disease
What Factors Predict Permanent Pacemaker Implantation after TAVR? CONDUCT-TAVI Outcomes
Permanent pacemaker implantation (PPM) for high grade atrioventricular block (AVB) continues to be one of the most...
Dr. Juan Manuel Pérez
-
17 October, 2025
Ir